Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

18 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Oral nitrate therapy does not affect glucose metabolism in healthy men.
Henstridge DC, Duffy SJ, Formosa MF, Ahimastos AA, Thompson BR, Kingwell BA. Henstridge DC, et al. Among authors: ahimastos aa. Clin Exp Pharmacol Physiol. 2009 Nov;36(11):1086-92. doi: 10.1111/j.1440-1681.2009.05195.x. Epub 2009 Apr 27. Clin Exp Pharmacol Physiol. 2009. PMID: 19413595 Clinical Trial.
Arterial stiffness and coronary ischemic disease.
Kingwell BA, Ahimastos AA. Kingwell BA, et al. Among authors: ahimastos aa. Adv Cardiol. 2007;44:125-138. doi: 10.1159/000096725. Adv Cardiol. 2007. PMID: 17075203 Review.
Reduced arterial stiffness may contribute to angiotensin-converting enzyme inhibitor induced improvements in walking time in peripheral arterial disease patients.
Ahimastos AA, Dart AM, Lawler A, Blombery PA, Kingwell BA. Ahimastos AA, et al. J Hypertens. 2008 May;26(5):1037-42. doi: 10.1097/HJH.0b013e3282f8e3b6. J Hypertens. 2008. Retraction in: J Hypertens. 2015 Dec;33(12):2552. doi: 10.1097/01.hjh.0000473689.35464.37. PMID: 18398348 Retracted. Clinical Trial.
A role for plasma transforming growth factor-beta and matrix metalloproteinases in aortic aneurysm surveillance in Marfan syndrome?
Ahimastos AA, Aggarwal A, Savarirayan R, Dart AM, Kingwell BA. Ahimastos AA, et al. Atherosclerosis. 2010 Mar;209(1):211-4. doi: 10.1016/j.atherosclerosis.2009.08.003. Epub 2009 Aug 8. Atherosclerosis. 2010. Retraction in: Atherosclerosis. 2016 Mar;246:385. doi: 10.1016/j.atherosclerosis.2016.01.027. PMID: 19717156 Retracted.
Effect of ramipril on walking times and quality of life among patients with peripheral artery disease and intermittent claudication: a randomized controlled trial.
Ahimastos AA, Walker PJ, Askew C, Leicht A, Pappas E, Blombery P, Reid CM, Golledge J, Kingwell BA. Ahimastos AA, et al. JAMA. 2013 Feb 6;309(5):453-60. doi: 10.1001/jama.2012.216237. JAMA. 2013. Retraction in: JAMA. 2015 Oct 13;314(14):1520-1. doi: 10.1001/jama.2015.10811. PMID: 23385271 Retracted. Clinical Trial.
Potential vascular mechanisms of ramipril induced increases in walking ability in patients with intermittent claudication.
Ahimastos AA, Latouche C, Natoli AK, Reddy-luthmoodoo M, Golledge J, Kingwell BA. Ahimastos AA, et al. Circ Res. 2014 Mar 28;114(7):1144-55. doi: 10.1161/CIRCRESAHA.114.302420. Epub 2014 Jan 7. Circ Res. 2014. Retraction in: Circ Res. 2015 Sep 11;117(7):e64. doi: 10.1161/RES.0000000000000072. PMID: 24397981 Retracted. Clinical Trial.
18 results